ELL2
Basic information
Region (hg38): 5:95885098-95961851
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 17 | 1 | 3 |
Variants in ELL2
This is a list of pathogenic ClinVar variants found in the ELL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-95891112-T-G | not specified | Uncertain significance (Feb 14, 2023) | ||
5-95898272-T-C | not specified | Uncertain significance (May 14, 2024) | ||
5-95898298-A-C | not specified | Uncertain significance (Jun 21, 2022) | ||
5-95898356-T-G | not specified | Uncertain significance (Dec 14, 2021) | ||
5-95898387-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
5-95898432-G-T | not specified | Uncertain significance (Nov 15, 2023) | ||
5-95898510-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
5-95898545-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
5-95898552-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
5-95898612-T-C | not specified | Likely benign (May 13, 2024) | ||
5-95898651-T-G | not specified | Uncertain significance (Oct 22, 2021) | ||
5-95898807-G-A | not specified | Uncertain significance (Jun 02, 2024) | ||
5-95900743-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
5-95900769-G-A | not specified | Uncertain significance (Apr 08, 2022) | ||
5-95906560-T-G | not specified | Uncertain significance (Jun 27, 2023) | ||
5-95906764-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
5-95913795-T-A | not specified | Uncertain significance (Dec 28, 2023) | ||
5-95913848-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
5-95917404-C-G | Benign (Jul 13, 2018) | |||
5-95919425-T-A | not specified | Uncertain significance (Mar 29, 2022) | ||
5-95919514-T-C | not specified | Uncertain significance (Oct 06, 2021) | ||
5-95924158-C-T | Benign (Jan 09, 2019) | |||
5-95929852-G-A | Benign (Jan 09, 2019) | |||
5-95943025-T-C | Likely benign (Jul 27, 2018) | |||
5-95961624-T-C | not specified | Uncertain significance (Apr 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ELL2 | protein_coding | protein_coding | ENST00000237853 | 12 | 76974 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00176 | 125743 | 0 | 5 | 125748 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.55 | 261 | 341 | 0.765 | 0.0000175 | 4162 |
Missense in Polyphen | 36 | 70.837 | 0.50821 | 940 | ||
Synonymous | -0.960 | 143 | 129 | 1.11 | 0.00000671 | 1221 |
Loss of Function | 4.73 | 3 | 31.7 | 0.0945 | 0.00000172 | 400 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000898 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968). Plays a role in immunoglobulin secretion in plasma cells: directs efficient alternative mRNA processing, influencing both proximal poly(A) site choice and exon skipping, as well as immunoglobulin heavy chain (IgH) alternative processing. Probably acts by regulating histone modifications accompanying transition from membrane- specific to secretory IgH mRNA expression. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23251033}.;
- Pathway
- Gene expression (Transcription);RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.141
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.91
Haploinsufficiency Scores
- pHI
- 0.444
- hipred
- Y
- hipred_score
- 0.647
- ghis
- 0.420
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.810
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ell2
- Phenotype
- immune system phenotype; skeleton phenotype; vision/eye phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- transcription elongation from RNA polymerase II promoter;snRNA transcription by RNA polymerase II
- Cellular component
- nucleoplasm;transcription elongation factor complex
- Molecular function
- protein binding